Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2010

Schmitt AC, Cohen C, Siddiqui MT. Paired box gene 8, HBME-1, and cytokeratin 19 expression in preoperative fine-needle aspiration of papillary thyroid carcinoma: diagnostic utility. Cancer Cytopathol. 2010;118(4):196-202.

Scognamiglio T, Zinchuk R, Gumpeni P, Larone DH. Comparison of inhibitory mold agar to Sabouraud dextrose agar as a primary medium for isolation of fungi. J Clin Microbiol. 2010;48(5):1924-5.

Miller JS, Chen YB, Ye H, Robinson BD, Brimo F, Epstein JI. Extraprostatic extension of prostatic adenocarcinoma on needle core biopsy: report of 72 cases with clinical follow-up. BJU Int. 2010;106(3):330-3.

Rickman DS, Chen Y-, Banerjee S, Pan Y, Yu J, Vuong T, et al. ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression. Neoplasia. 2010;12(12):1031-40.

Koolaee RM, Singer O, Bass A, Winchester R, Seshan S, Erkan D. Hepatitis C- and human immunodeficiency virus-induced hypersensitivity vasculitis: a clinical pathology conference held by the division of rheumatology at hospital for special surgery. HSS J. 2010;6(1):102-7.

Simonson PD, Deberg HA, Ge P, Alexander JK, Jeyifous O, Green WN, et al. Counting bungarotoxin binding sites of nicotinic acetylcholine receptors in mammalian cells with high signal/noise ratios. Biophys J. 2010;99(10):L81-3.

Flavin R, Peluso S, Nguyen PL, Loda M. Fatty acid synthase as a potential therapeutic target in cancer. Future Oncol. 2010;6(4):551-62.

Dentice M, Marsili A, Ambrosio R, Guardiola O, Sibilio A, Paik J-, et al. The FoxO3/type 2 deiodinase pathway is required for normal mouse myogenesis and muscle regeneration. J Clin Invest. 2010;120(11):4021-30.

Fonseca R, Richardson P, Giralt S, Lonial S, S Rajkumar V, A Stewart K, et al. Conflicts of interest, authorship, and disclosures in industry-related scientific publications. Mayo Clin Proc. 2010;85(2):197-9; author reply 201-4.

DeSancho MT, Berlus N, Christos PJ, Rand J. Risk factors for clinical manifestations in carriers of Factor V Leiden and prothrombin gene mutations. Blood Coagul Fibrinolysis. 2010;21(1):11-5.